External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ASN 2020

-
Coming soon
05:00 PM
Duration 8mins Virtual
Two-Year Results From a Randomized, Controlled Study of Obinutuzumab For Proliferative Lupus Nephritis
Rovin BH, Aroca G, Alvarez A, Fragoso-Loyo H, Santillán EZ, Furie R, Brunetta P, Schindler T, Hassan I, Cascino MD, Garg JP, Malvar A

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar